Suppr超能文献

摩洛哥南部健康人群中可能与多发性硬化症相关的主要HLA-A、-B、-DR和-DQ基因座的分布

Distribution of Major HLA-A, -B, -DR, and -DQ Loci Potentially Associated with Multiple Sclerosis in a Healthy Population from Southern Morocco.

作者信息

Fguirouche Abir, Ouahmani Fatimazahra, Brahim Ikram, Hazime Raja, Louhab Nissrine, Kissani Najib, Chraa Mohamed, Admou Brahim

机构信息

Laboratory of immunology and HLA, Center of Clinical Research, Mohammed VI University Hospital, Marrakech 43150, Morocco.

Biosciences Research Laboratory, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech 40000, Morocco.

出版信息

Clin Pract. 2025 Jan 2;15(1):10. doi: 10.3390/clinpract15010010.

Abstract

Many factors contribute to the development and the progression of Multiple Sclerosis (MS), including Human Leukocyte Antigen (HLA) molecules. Some of them are considered as predisposing, like DRB115, DRB113, DRB103, DRB104, DQB106, DQB102, while HLA A2, HLA B44, DRB111, and DRB112 are rather considered as protective. Data about such associations in the Moroccan population remain unknown. The aim of this study was to determine the frequency of HLA class I (A and B) and II (DR and DQ) linked to Multiple Sclerosis (MS) in a healthy population from the South of Morocco. A cross-sectional study was carried out over the 2016-2023 period on 685 Moroccan healthy individuals, including 355 males and 330 females. Of the total sample tested, 685 underwent HLA class I typing, of which 305 also benefited from HLA class II typing. HLA class I typing was executed using the CDC (complement dependent cytotoxicity) technique (OneLambda™, Los Angeles CA, USA), and HLA class II typing was performed by either PCR-SSP (sequence-specific primer, OneLambda) or PCR-SSO (sequence-specific oligonucleotides) using the Luminex Xmap (Lifecodes, Immucor, Peachtree, Corners, GA, USA) system. From different HLA molecules potentially predisposing to MS, our investigations showed that DRB103, DRB113, DRB115, DRB104, and DQB102 were observed in 19.2%, 15.8%, 13.31%, 12.7% and 31% respectively, while the frequency of those considered as protective, namely HLA-A2, HLA-B44, and HLA-DRB111 was 23.31%, 9.21% and 10.1% respectively. The findings of our study give evidence that among predisposing HLA class II molecules, DR allele groups were more prevalent, mostly DRB103, with also a high frequency of DQB106, while HLA-A2 marked the supposed protective specificities. These results need to be supported by complementary studies particularly in MS patients.

摘要

多种因素促成了多发性硬化症(MS)的发生和发展,包括人类白细胞抗原(HLA)分子。其中一些被认为是易感因素,如DRB115、DRB113、DRB103、DRB104、DQB106、DQB102,而HLA A2、HLA B44、DRB111和DRB112则被认为具有保护作用。摩洛哥人群中此类关联的数据仍然未知。本研究的目的是确定摩洛哥南部健康人群中与多发性硬化症(MS)相关的HLA I类(A和B)和II类(DR和DQ)的频率。在2016年至2023年期间对685名摩洛哥健康个体进行了一项横断面研究,其中包括355名男性和330名女性。在测试的总样本中,685人进行了HLA I类分型,其中305人还进行了HLA II类分型。HLA I类分型采用CDC(补体依赖细胞毒性)技术(美国加利福尼亚州洛杉矶的OneLambda™)进行,HLA II类分型通过使用Luminex Xmap(美国佐治亚州皮茨特里角的Lifecodes、Immucor)系统的PCR-SSP(序列特异性引物,OneLambda)或PCR-SSO(序列特异性寡核苷酸)进行。在可能易患MS的不同HLA分子中,我们的研究表明,DRB103、DRB113、DRB115、DRB104和DQB102的观察频率分别为19.2%、15.8%、13.31%、12.7%和31%,而被认为具有保护作用的分子,即HLA-A2、HLA-B44和HLA-DRB111的频率分别为23.31%、9.21%和10.1%。我们的研究结果表明,在易患MS的HLA II类分子中,DR等位基因组更为普遍,主要是DRB103,DQB106的频率也较高,而HLA-A2则代表了假定的保护特异性。这些结果需要补充研究的支持,特别是在MS患者中。

相似文献

本文引用的文献

4
The immunogenetics of multiple sclerosis: A comprehensive review.多发性硬化症的免疫遗传学:全面综述。
J Autoimmun. 2015 Nov;64:13-25. doi: 10.1016/j.jaut.2015.06.010. Epub 2015 Jul 2.
9
HLA class II alleles and multiple sclerosis in Tunisian patients.突尼斯患者的HLA II类等位基因与多发性硬化症
Clin Neurol Neurosurg. 2010 Dec;112(10):849-52. doi: 10.1016/j.clineuro.2010.07.004. Epub 2010 Aug 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验